EXPRESSION AND FUNCTION OF FAS ANTIGEN AND BCL-2 IN HUMAN SYSTEMIC LUPUS-ERYTHEMATOSUS LYMPHOCYTES

被引:86
作者
OHSAKO, S
HARA, M
HARIGAI, M
FUKASAWA, C
KASHIWAZAKI, S
机构
[1] Institute of Rheumatology, Tokyo Women’s Medical College, Shinjuku-ku, Tokyo 162, 9-12, Wakamatsu-cho
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1994年 / 73卷 / 01期
关键词
D O I
10.1006/clin.1994.1176
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Studies indicate that autoimmune phenomena might be caused by a failure to eliminate autoreactive lymphocytes. Therefore, we examined Fas antigen and bcl-2 expression and function in lymphocytes from human systemic lupus erythematosus (SLE) patients. Freshly isolated lymphocytes from patients with active SLE expressed more Fas antigen than did lymphocytes from patients with inactive SLE or from normal controls. They also showed characteristic DNA fragmentation after treatment with anti-Fas antibody. Expression of bcl-2 in T cells from active SLE patients was significantly higher than that in cells from inactive SLE patients and from normals. These data suggest that lymphocytes in patients with active SLE maintain an activated state in vivo. However, the role of Fas and bcl-2 expression in the regulation of lymphocyte survival in SLE is still unclear and further investigations concerning the role of these molecules in autoimmune phenomenon in SLE are needed. (C) 1994 Academic Press, Inc.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 35 条
[1]   FLOW CYTOMETRIC DETECTION OF THE MITOCHONDRIAL BCL-2 PROTEIN IN NORMAL AND NEOPLASTIC HUMAN LYMPHOID-CELLS [J].
AIELLO, A ;
DELIA, D ;
BORRELLO, MG ;
BIASSONI, D ;
GIARDINI, R ;
FONTANELLA, E ;
PEZZELLA, F ;
PULFORD, K ;
PIEROTTI, M ;
DELLAPORTA, G .
CYTOMETRY, 1992, 13 (05) :502-509
[2]   A POSSIBLE ROLE FOR BCL-2 IN REGULATING T-CELL MEMORY - A BALANCING ACT BETWEEN CELL-DEATH AND SURVIVAL [J].
AKBAR, AN ;
SALMON, M ;
SAVILL, J ;
JANOSSY, G .
IMMUNOLOGY TODAY, 1993, 14 (11) :526-532
[3]   FAS TRANSDUCES ACTIVATION SIGNALS IN NORMAL HUMAN T-LYMPHOCYTES [J].
ALDERSON, MR ;
ARMITAGE, RJ ;
MARASKOVSKY, E ;
TOUGH, TW ;
ROUX, E ;
SCHOOLEY, K ;
RAMSDELL, F ;
LYNCH, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2231-2235
[4]   PROTECTION FROM FAS-MEDIATED APOPTOSIS BY A SOLUBLE FORM OF THE FAS MOLECULE [J].
CHENG, JH ;
ZHOU, T ;
LIU, CD ;
SHAPIRO, JP ;
BRAUER, MJ ;
KIEFER, MC ;
BARR, PJ ;
MOUNTZ, JD .
SCIENCE, 1994, 263 (5154) :1759-1762
[5]   PREVENTION OF PROGRAMMED CELL-DEATH OF SYMPATHETIC NEURONS BY THE BCL-2 PROTOONCOGENE [J].
GARCIA, I ;
MARTINOU, I ;
TSUJIMOTO, Y ;
MARTINOU, JC .
SCIENCE, 1992, 258 (5080) :302-304
[6]  
GRATIOTDEANS J, 1993, J IMMUNOL, V151, P83
[7]   DIFFERENTIAL ABNORMALITY IN CELL-CYCLE STAGE OF PERIPHERAL B-CELLS FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
HARA, M ;
KITANI, A ;
HARIGAI, M ;
HIROSE, T ;
NORIOKA, K ;
HIROSE, W ;
SUZUKI, K ;
KAWAGOE, M ;
NAKAMURA, H .
RHEUMATOLOGY INTERNATIONAL, 1987, 7 (02) :83-87
[8]   ELIMINATION OF SELF-REACTIVE LYMPHOCYTES-B PROCEEDS IN 2 STAGES - ARRESTED DEVELOPMENT AND CELL-DEATH [J].
HARTLEY, SB ;
COOKE, MP ;
FULCHER, DA ;
HARRIS, AW ;
CORY, S ;
BASTEN, A ;
GOODNOW, CC .
CELL, 1993, 72 (03) :325-335
[9]  
ITOH N, 1993, J BIOL CHEM, V268, P10932
[10]  
ITOH N, 1993, J IMMUNOL, V151, P621